These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7961208)

  • 21. Antibacterial activity of cefixime against Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae in the presence of Moraxella (Branhamella) catarrhalis.
    Yamada T; Yokota Y; Ikeda F; Mine Y; Kitada T
    Chemotherapy; 1992; 38(1):28-35. PubMed ID: 1618001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmid-mediated beta-lactamase in Branhamella catarrhalis.
    Kamme C; Eliasson I; Knutson BK; Vang M
    Drugs; 1986; 31 Suppl 3():55-63. PubMed ID: 3488198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Branhamella catarrhalis pneumonia: report of 4 cases.
    Yen MY; Tsai IK; Cheng DL; Liu YC; Liu CY; Wang LS
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):610-6. PubMed ID: 2507737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993.
    Nissinen A; Grönroos P; Huovinen P; Herva E; Katila ML; Klaukka T; Kontiainen S; Liimatainen O; Oinonen S; Mäkelä PH
    Clin Infect Dis; 1995 Nov; 21(5):1193-6. PubMed ID: 8589142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Susceptibility of Branhamella catarrhalis to antibiotics].
    Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
    Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial resistance in Branhamella catarrhalis.
    Riley TV
    J Antimicrob Chemother; 1988 Feb; 21(2):147-50. PubMed ID: 3129387
    [No Abstract]   [Full Text] [Related]  

  • 27. Multipoint microbiological assay for detecting beta-lactamase.
    Thickett KJ; Winstanley TG
    J Clin Pathol; 1991 May; 44(5):435-6. PubMed ID: 1904456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of Moraxella catarrhalis from sputum specimens of Malaysian patients.
    Ahmad N; Cheong YM; Tahir HM
    Malays J Pathol; 1994 Jun; 16(1):63-7. PubMed ID: 16329578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro activity of roxithromycin against Branhamella catarrhalis.
    Spencer RC; Wheat PF
    J Antimicrob Chemother; 1990 Jul; 26(1):153-5. PubMed ID: 2120171
    [No Abstract]   [Full Text] [Related]  

  • 30. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumonia due to Moraxella (Branhamella) catarrhalis.
    Wright PW; Wallace RJ
    Semin Respir Infect; 1989 Mar; 4(1):40-6. PubMed ID: 2496450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A; Janicka G; Krawiecka D; Kochanowska J
    Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE; Slocombe B; White AR
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility and beta-lactamase production of Moraxella catarrhalis isolates in Taiwan.
    Fung CP; Jang TN; Liu CY; Lau YJ; Liu YC; Chuang YC; Lee N
    J Formos Med Assoc; 1995 Sep; 94(9):548-54. PubMed ID: 8696169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults.
    Khan MA; Northwood JB; Levy F; Verhaegh SJ; Farrell DJ; Van Belkum A; Hays JP
    J Antimicrob Chemother; 2010 Jan; 65(1):91-7. PubMed ID: 19889789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contemporary prevalence of BRO beta-lactamases in Moraxella catarrhalis: report from the SENTRY antimicrobial surveillance program (North America, 1997 to 2004).
    Deshpande LM; Sader HS; Fritsche TR; Jones RN
    J Clin Microbiol; 2006 Oct; 44(10):3775-7. PubMed ID: 17021108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
    Cooper CE; Slocombe B; White AR
    J Chemother; 1989 Jul; 1(4 Suppl):350-1. PubMed ID: 16312434
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of beta-lactamase in mixed infections in mice in relation to treatment with ampicillin.
    Renneberg J; Walder M
    J Infect Dis; 1989 Aug; 160(2):337-41. PubMed ID: 2503565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRO beta-lactamase alleles, antibiotic resistance and a test of the BRO-1 selective replacement hypothesis in Moraxella catarrhalis.
    Levy F; Walker ES
    J Antimicrob Chemother; 2004 Feb; 53(2):371-4. PubMed ID: 14729761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.